| Intrinsic Valuation of: FLUOROCHEM | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 50 | Market Cap | ₹399B | |||||
| 2021 | - | - (-) | P/E Ratio | 72 | Total Asset | ₹106B | |||||
| 2022 | ₹674M | - (-) | Net Income | ₹5B | Total Debt | ₹4B | |||||
| 2023 | ₹76M | -88.8% (-92.1%) | EBITDA | ₹12B | Total Liab | ₹33B | |||||
| 2024 | ₹-3B | -4678.5% (-6083.0%) | Opr Margin | 0.16 | Debt/Equity | 0.05 | |||||
| 2025 | ₹-3B | 2.9% (12.2%) | PreTax Margin | 12.60 | BV/Share | 652 | |||||
| 5Y Average FCF | ₹-2B | -1588.1% (-2054.3%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (4.0%) | ||||||||||
| 2026 | ₹-2B | MBG Intrinsic Value | ₹443 | ||||||||
| 2027 | ₹-2B | ||||||||||
| 2028 | ₹-2B | ||||||||||
| 2029 | ₹-2B | ||||||||||
| 2030 | ₹-2B | ||||||||||
| 2031 | ₹-2B | ||||||||||
| Terminal Value | ₹-40B | Net Worth/Share | ₹664 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹-34B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹550M | ₹-342 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹4B | WACC | 7.3% | -305 | -324 | -348 | -378 | -415 | |||
| Equity Value | ₹-38B | 7.4% | -302 | -322 | -345 | -374 | -410 | ||||
| Shares Outstanding | 109,850,000 | 7.4% | -300 | -319 | -342 | -370 | -405 | ||||
| 7.9% | -279 | -294 | -313 | -335 | -362 | ||||||
| DCF Intrinsic Value | ₹-342 | 8.4% | -261 | -274 | -289 | -307 | -329 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||